Individualized Fortification of Breast Milk for Preterm Infants

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02865941` - Target Fortification of Breast Milk: How Often Breast Milk Needs to be Measured?	N/A
Completed	`NCT03889197` - Physiologic Approach to Sodium Supplementation in Premature Infants	Phase 4
Recruiting	`NCT01609894` - Individualized Fortification of Breast Milk	N/A
Completed	`NCT01367015` - Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF)	N/A

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT02865941 - Target Fortification of Breast Milk: How Often Breast Milk Needs to be Measured?

N/A

Completed

NCT03889197 - Physiologic Approach to Sodium Supplementation in Premature Infants

Phase 4

Recruiting

NCT01609894 - Individualized Fortification of Breast Milk

N/A

Completed

NCT01367015 - Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF)

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01305642
Study type	Interventional
Source	McMaster Children's Hospital
Contact
Status	Completed
Phase	N/A
Start date	February 2011
Completion date	December 2011

Individualized Fortification of Breast Milk for Preterm Infants - A Pilot Study — IFO Pilot

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms